BTIG cuts Steven Madden stock target to $46, maintains Buy
BTIG analyst Janine Stichter adjusted the price target for Steven Madden (NASDAQ: NASDAQ:SHOO) shares to $46.00, down from ...
Steven Madden price target lowered to $46 from $52 at BTIG
BTIG lowered the firm’s price target on Steven Madden (SHOO) to $46 from $52 and keeps a Buy rating on the shares after meeting with its ...
BTIG says Paysafe could be worth $40 in sale, sees suitors as strategic buyers
BTIG notes that Bloomberg reported earlier that Buy-rated Paysafe (PSFE) is exploring a sale after receiving takeover interest. The article ...
BTIG raises Roblox stock price target to $73, maintains Buy rating
BTIG analyst Clark Lampen adjusted the price target for Roblox Corp . (NYSE:RBLX) shares, raising it to $73 from the previous $66, while maintaining a Buy rating on the stock. The reevaluation ...
Performant to Participate in the Upcoming BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference
Performant Healthcare, Inc. (Nasdaq: PHLT) ("Performant"), a leading provider of technology-enabled payment integrity, eligibility, and related analytics services, announced today that it will ...
Lucid Diagnostics to Participate in the 12th Annual BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference
Lucid Diagnostics Inc. (Nasdaq: LUCD) ("Lucid" or the "Company"), a commercial-stage, cancer prevention medical diagnostics company and subsidiary of PAVmed Inc. (Nasdaq: PAVM), today announced its ...
Paysafe may be worth $40 a share in potential takeover - analyst
Paysafe (PSFE) could be valued at $40 a share in a potential acquisition, as the payments firm explores sale options with strategic buyers, according to ...
TMCnet4d
HOPE Therapeutics™, Inc. and NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Engage BTIG as Financial Advisor
BTIG is a leading global financial services firm specializing in investment banking, institutional trading, research, and ...